ZA200203003B - N-substituted carbamoyloxyalkyl-azolium derivatives. - Google Patents

N-substituted carbamoyloxyalkyl-azolium derivatives.

Info

Publication number
ZA200203003B
ZA200203003B ZA200203003A ZA200203003A ZA200203003B ZA 200203003 B ZA200203003 B ZA 200203003B ZA 200203003 A ZA200203003 A ZA 200203003A ZA 200203003 A ZA200203003 A ZA 200203003A ZA 200203003 B ZA200203003 B ZA 200203003B
Authority
ZA
South Africa
Prior art keywords
azolium
derivatives
carbamoyloxyalkyl
substituted
substituted carbamoyloxyalkyl
Prior art date
Application number
ZA200203003A
Other languages
English (en)
Inventor
Hiroshi Fukuda
Eisaku Mizuguchi
Jun Ohwada
Masahiro Sakaitani
Isao Umeda
Tadakatsu Hayase
Nobuo Shimma
Nobuhiro Oikawa
Masao Tsukazaki
Original Assignee
Basilea Pharmaceutica Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basilea Pharmaceutica Ag filed Critical Basilea Pharmaceutica Ag
Publication of ZA200203003B publication Critical patent/ZA200203003B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cephalosporin Compounds (AREA)
ZA200203003A 1999-11-02 2002-04-16 N-substituted carbamoyloxyalkyl-azolium derivatives. ZA200203003B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP99121694 1999-11-02

Publications (1)

Publication Number Publication Date
ZA200203003B true ZA200203003B (en) 2003-09-23

Family

ID=8239312

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200203003A ZA200203003B (en) 1999-11-02 2002-04-16 N-substituted carbamoyloxyalkyl-azolium derivatives.

Country Status (22)

Country Link
EP (1) EP1280795B1 (nl)
JP (1) JP3787307B2 (nl)
KR (1) KR100449797B1 (nl)
CN (1) CN1185230C (nl)
AR (1) AR029403A1 (nl)
AT (1) ATE291575T1 (nl)
AU (1) AU777859B2 (nl)
BE (1) BE2016C007I2 (nl)
BR (1) BRPI0015254C1 (nl)
CA (2) CA2388320C (nl)
CY (1) CY2016002I1 (nl)
DE (1) DE60018989T2 (nl)
DK (1) DK1280795T3 (nl)
ES (1) ES2238341T3 (nl)
FR (1) FR15C0096I2 (nl)
LU (1) LU92939I2 (nl)
MX (1) MXPA02004145A (nl)
NL (1) NL300791I2 (nl)
PT (1) PT1280795E (nl)
TR (1) TR200201205T2 (nl)
WO (1) WO2001032652A2 (nl)
ZA (1) ZA200203003B (nl)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY148805A (en) 2002-10-16 2013-05-31 Takeda Pharmaceutical Controlled release preparation
PT2192893E (pt) 2007-08-21 2015-11-09 Basilea Pharmaceutica Ag Composição antifúngica
AU2012272804B2 (en) 2011-06-22 2017-07-06 Vyome Therapeutics Limited Conjugate-based antifungal and antibacterial prodrugs
MX2015016675A (es) 2013-06-04 2016-07-15 Vyome Biosciences Pvt Ltd Particulas recubiertas y composiciones que comprenden las mismas.
CN104230894B (zh) * 2013-06-06 2016-08-24 南京华威医药科技开发有限公司 三唑类化合物
AU2015380298B2 (en) * 2014-12-30 2019-02-21 Corteva Agriscience Llc Picolinamide compounds with fungicidal activity
CN106032356B (zh) * 2015-03-13 2018-09-14 江苏正大丰海制药有限公司 一种[n-甲基-吡啶-2-基]氨基甲酸-1-氯乙酯的制备方法
CN104974143A (zh) * 2015-05-12 2015-10-14 深圳致君制药有限公司 一种季铵盐类化合物、其制备方法以及用途
CN106467519B (zh) * 2015-08-17 2019-08-13 南京华威医药科技集团有限公司 一种水溶性三唑化合物
CN106467534B (zh) * 2015-08-17 2019-10-11 江苏奥赛康药业有限公司 一种硫酸艾沙康唑鎓化合物及其药物组合物
CN106565699B (zh) * 2015-10-10 2019-07-26 江苏正大丰海制药有限公司 一种艾沙康唑硫酸盐晶体及其制备方法
WO2018067702A1 (en) 2016-10-04 2018-04-12 Massachusetts Institute Of Technology Bottlebrush copolymers and uses thereof
CN108456194B (zh) * 2017-02-17 2021-06-22 武汉朗来科技发展有限公司 三氮唑抗菌衍生物、其药物组合物和用途
CN106916152B (zh) * 2017-04-27 2019-09-17 扬子江药业集团有限公司 氧化还原反应制备艾沙康唑鎓单硫酸盐的方法
JP7187048B2 (ja) 2017-06-30 2022-12-12 マサチューセッツ インスティテュート オブ テクノロジー 分枝多官能性マクロモノマーおよび関連ポリマーならびにそれらの使用
US11752221B2 (en) 2017-06-30 2023-09-12 Massachusetts Institute Of Technology Brush-arm star polymer imaging agents and uses thereof
US10368502B2 (en) 2017-09-25 2019-08-06 Multiple Energy Technologies Llc Bioceramic and carbon-based hydroponic systems, methods and devices
CN110317165A (zh) * 2018-03-28 2019-10-11 上海医药工业研究院 一种药物中间体2-甲胺基-3-吡啶甲醇的制备方法
CN110551064B (zh) * 2018-06-01 2021-01-01 重庆世森医药科技有限公司 艾沙康唑硫酸酯及其中间体的制备方法
KR20210040034A (ko) 2018-08-01 2021-04-12 바실리어 파마슈티카 인터내셔널 리미티드 이사부코나조늄 설페이트의 정제 방법
US10988491B2 (en) 2018-08-17 2021-04-27 Massachusetts Institute Of Technology Degradable polymers of a cyclic silyl ether and uses thereof
CN110128420A (zh) * 2019-05-08 2019-08-16 阴启明 硫酸氢根/硫酸根型阴离子交换技术制备艾沙康唑鎓单硫酸盐的方法
US20220289735A1 (en) 2019-08-26 2022-09-15 Synthon B.V. Isavuconazonium salts and process for preparing thereof
CA3154334A1 (en) * 2019-10-16 2021-04-22 Jeremiah A. Johnson Brush prodrugs and uses thereof
WO2021141662A1 (en) 2020-01-10 2021-07-15 Massachusetts Institute Of Technology Proteolysis targeting chimeric molecules (protacs) with functional handles and uses thereof
JP7454905B2 (ja) * 2021-09-28 2024-03-25 旭化成ファーマ株式会社 有効成分であるイサブコナゾール又はそのプロドラッグを含有する真菌症治療及び/又は予防剤
WO2023054310A1 (en) 2021-09-28 2023-04-06 Basilea Pharmaceutica International Ag, Allschwil Intravenous drip infusion set provided with air-vented infusion filter
WO2023121753A1 (en) 2021-12-20 2023-06-29 Massachusetts Institute Of Technology Biomolecule-polymer-pharmaceutical agent conjugates for delivering the pharmaceutical agent
EP4289840A1 (en) 2022-06-07 2023-12-13 Zaklady Farmaceutyczne Polpharma S.A. A process for preparing isavuconazonium sulfate
WO2024094329A1 (en) 2022-11-01 2024-05-10 Basilea Pharmaceutica International Ag, Allschwil Blister-packaged capsule preparation containing isavuconazonium sulfate
WO2024189550A1 (en) * 2023-03-13 2024-09-19 Apitoria Pharma Private Limited Process for the preparation of isavuconazonium sulfate and its crystalline forms

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3108997B2 (ja) * 1997-03-31 2000-11-13 武田薬品工業株式会社 アゾール化合物、その製造法および用途
ATE244715T1 (de) * 1997-03-31 2003-07-15 Takeda Chemical Industries Ltd Azol-verbindungen, ihre herstellung und ihre verwendung
AU2931399A (en) * 1998-03-06 1999-09-20 F. Hoffmann-La Roche Ag 3-(4-(4-cyanophenyl)thiazol-2-y))-1-(1h-1,2,4-triazol-1-yl) -butan-2-ol derivatives having antifungal activity

Also Published As

Publication number Publication date
ATE291575T1 (de) 2005-04-15
CA2680292C (en) 2012-11-27
EP1280795B1 (en) 2005-03-23
BE2016C007I2 (nl) 2019-10-23
CY2016002I2 (el) 2016-10-05
WO2001032652A3 (en) 2001-11-15
KR100449797B1 (ko) 2004-09-30
AU2835201A (en) 2001-05-14
CA2388320C (en) 2009-12-15
DE60018989D1 (de) 2005-04-28
CN1185230C (zh) 2005-01-19
PT1280795E (pt) 2005-06-30
BR0015254B1 (pt) 2013-05-21
LU92939I2 (fr) 2016-03-07
ES2238341T9 (es) 2016-03-02
JP2003513090A (ja) 2003-04-08
FR15C0096I2 (fr) 2016-04-22
KR20020062298A (ko) 2002-07-25
MXPA02004145A (es) 2002-10-17
FR15C0096I1 (nl) 2016-02-12
BRPI0015254C1 (pt) 2021-05-25
BR0015254A (pt) 2002-06-25
AR029403A1 (es) 2003-06-25
JP3787307B2 (ja) 2006-06-21
WO2001032652A2 (en) 2001-05-10
BRPI0015254B8 (pt) 2017-04-25
NL300791I1 (nl) 2016-03-15
DE60018989T2 (de) 2005-08-18
EP1280795A2 (en) 2003-02-05
CA2388320A1 (en) 2001-05-10
NL300791I2 (nl) 2016-03-15
CN1387529A (zh) 2002-12-25
ES2238341T3 (es) 2005-09-01
AU777859B2 (en) 2004-11-04
DK1280795T3 (da) 2005-07-18
CY2016002I1 (el) 2016-10-05
CA2680292A1 (en) 2001-05-10
TR200201205T2 (tr) 2002-08-21

Similar Documents

Publication Publication Date Title
ZA200203003B (en) N-substituted carbamoyloxyalkyl-azolium derivatives.
HK1041885A1 (en) Amide derivatives.
ZA200000894B (en) 4-Phenyl-pyridine derivatives.
ZA200201055B (en) Amino-triazolopyridine derivatives.
HUP0201535A2 (en) 5-cyano-2-aminopyrimidine derivatives
GC0000183A (en) 3-Phenyl-pyridine derivatives
ZA200109595B (en) 13-methyl-erythromycin derivatives.
HK1046411A1 (en) 5-Phenyl-pyrimidine derivatives.
IL148837A0 (en) Isoxazolecarboxamide derivatives
GC0000191A (en) 4-Phenyl-pyrimidine derivatives
MXPA00011504A (es) Derivados heterociclicos sustituidos.
GB9925880D0 (en) B-Carboline derivatives
ZA200201276B (en) 3-Amino-2-phenyl-propane derivatives.
IL150132A0 (en) Cyclopenteneone derivatives
GC0000256A (en) Ethanesulfonyl-piperidine derivatives
AP2001002327A0 (en) 1-Trifluoromethyl-4-hydroxy-7- piperidinylaminomethy lchroman derivatives
MXPA01011285A (es) Derivados de tio-oxindol.
ZA200204492B (en) Heterocyclic derivatives.
ZA200107536B (en) Amide derivatives.
ZA993232B (en) Arylthiazolidinedione derivatives.
ZA200107632B (en) Thio-oxindole derivatives.
ZA200203703B (en) New Phenalkyloxy-phenyl derivatives.
GB9907134D0 (en) Antimor napthylcombretastatin derivatives
IL146282A0 (en) Thio-oxindole derivatives
HK1043987A1 (zh) 硫-羥吲衍生物